Advertisement
New Zealand Markets closed
  • NZX 50

    11,755.17
    +8.59 (+0.07%)
     
  • NZD/USD

    0.6031
    -0.0003 (-0.0422%)
     
  • NZD/EUR

    0.5590
    -0.0004 (-0.07%)
     
  • ALL ORDS

    8,022.70
    +28.50 (+0.36%)
     
  • ASX 200

    7,749.00
    +27.40 (+0.35%)
     
  • OIL

    79.70
    +0.44 (+0.56%)
     
  • GOLD

    2,373.90
    +33.60 (+1.44%)
     
  • NASDAQ

    18,216.58
    +103.11 (+0.57%)
     
  • FTSE

    8,435.98
    +54.63 (+0.65%)
     
  • Dow Jones

    39,546.47
    +158.71 (+0.40%)
     
  • DAX

    18,764.29
    +77.69 (+0.42%)
     
  • Hang Seng

    18,963.68
    +425.87 (+2.30%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     
  • NZD/JPY

    93.8860
    +0.1180 (+0.13%)
     

COVID Concerns Are Rising in China Again: Will This Send Moderna's Stock Soaring?

COVID Concerns Are Rising in China Again: Will This Send Moderna's Stock Soaring?

The number of people with COVID-19 has been rising rapidly in China in recent weeks, and there are concerns that the government in Beijing could consider reviving its strict lockdown policies again. COVID-19 cases have been surging in China, largely due to the spread of the omicron XBB variants. In February, the Centers for Disease Control and Prevention pointed to early study results showing that for the bivalent vaccine boosters created to target omicron variants, "[vaccine effectiveness] was generally similar against BA.5-related infections [original omicron] and XBB/XBB.1.5-related infections."